Galenica AG
Galenica AG (GALNF) Stock Competitors & Peer Comparison
See (GALNF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GALNF | $75.25 | +0.00% | 3.7B | 20.23 | $3.72 | +3.71% |
| SHTDY | $12.41 | +0.19% | 7.8B | 7.84 | $1.58 | +3.79% |
| SHTDF | $2.40 | +0.00% | 7.5B | 7.50 | $0.32 | +3.91% |
| SHPMF | $1.29 | -17.83% | 7.1B | 8.06 | $0.16 | +4.00% |
| SHPMY | $8.00 | -0.74% | 5.9B | 9.76 | $0.82 | +2.45% |
| CAKFY | $4.10 | +0.00% | 5.4B | -68.33 | -$0.06 | N/A |
| AMFPF | $22.43 | -1.88% | 5B | 30.31 | $0.74 | +1.45% |
| MAHLY | $16.48 | +0.00% | 3.4B | 12.58 | $1.31 | +1.67% |
| MEPDF | $15.90 | +0.00% | 3.3B | 12.14 | $1.31 | +2.66% |
| ALFRY | $15.99 | +0.00% | 2.9B | 15.99 | $1.00 | N/A |
Stock Comparison
GALNF vs SHTDY Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, SHTDY has a market cap of 7.8B. Regarding current trading prices, GALNF is priced at $75.25, while SHTDY trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas SHTDY's P/E ratio is 7.84. In terms of profitability, GALNF's ROE is +0.12%, compared to SHTDY's ROE of +0.09%. Regarding short-term risk, GALNF is less volatile compared to SHTDY. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check SHTDY's competition here
GALNF vs SHTDF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, SHTDF has a market cap of 7.5B. Regarding current trading prices, GALNF is priced at $75.25, while SHTDF trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas SHTDF's P/E ratio is 7.50. In terms of profitability, GALNF's ROE is +0.12%, compared to SHTDF's ROE of +0.06%. Regarding short-term risk, GALNF and SHTDF have similar daily volatility (0.00).Check SHTDF's competition here
GALNF vs SHPMF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, SHPMF has a market cap of 7.1B. Regarding current trading prices, GALNF is priced at $75.25, while SHPMF trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas SHPMF's P/E ratio is 8.06. In terms of profitability, GALNF's ROE is +0.12%, compared to SHPMF's ROE of +0.06%. Regarding short-term risk, GALNF and SHPMF have similar daily volatility (0.00).Check SHPMF's competition here
GALNF vs SHPMY Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, SHPMY has a market cap of 5.9B. Regarding current trading prices, GALNF is priced at $75.25, while SHPMY trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas SHPMY's P/E ratio is 9.76. In terms of profitability, GALNF's ROE is +0.12%, compared to SHPMY's ROE of +0.06%. Regarding short-term risk, GALNF and SHPMY have similar daily volatility (0.00).Check SHPMY's competition here
GALNF vs CAKFY Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, CAKFY has a market cap of 5.4B. Regarding current trading prices, GALNF is priced at $75.25, while CAKFY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas CAKFY's P/E ratio is -68.33. In terms of profitability, GALNF's ROE is +0.12%, compared to CAKFY's ROE of -0.02%. Regarding short-term risk, GALNF and CAKFY have similar daily volatility (0.00).Check CAKFY's competition here
GALNF vs AMFPF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, AMFPF has a market cap of 5B. Regarding current trading prices, GALNF is priced at $75.25, while AMFPF trades at $22.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas AMFPF's P/E ratio is 30.31. In terms of profitability, GALNF's ROE is +0.12%, compared to AMFPF's ROE of +0.13%. Regarding short-term risk, GALNF is less volatile compared to AMFPF. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check AMFPF's competition here
GALNF vs MAHLY Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, MAHLY has a market cap of 3.4B. Regarding current trading prices, GALNF is priced at $75.25, while MAHLY trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas MAHLY's P/E ratio is 12.58. In terms of profitability, GALNF's ROE is +0.12%, compared to MAHLY's ROE of +0.07%. Regarding short-term risk, GALNF is less volatile compared to MAHLY. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check MAHLY's competition here
GALNF vs MEPDF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, MEPDF has a market cap of 3.3B. Regarding current trading prices, GALNF is priced at $75.25, while MEPDF trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas MEPDF's P/E ratio is 12.14. In terms of profitability, GALNF's ROE is +0.12%, compared to MEPDF's ROE of +0.07%. Regarding short-term risk, GALNF is less volatile compared to MEPDF. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check MEPDF's competition here
GALNF vs ALFRY Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, ALFRY has a market cap of 2.9B. Regarding current trading prices, GALNF is priced at $75.25, while ALFRY trades at $15.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas ALFRY's P/E ratio is 15.99. In terms of profitability, GALNF's ROE is +0.12%, compared to ALFRY's ROE of +0.06%. Regarding short-term risk, GALNF and ALFRY have similar daily volatility (0.00).Check ALFRY's competition here
GALNF vs ARHCF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, ARHCF has a market cap of 2.2B. Regarding current trading prices, GALNF is priced at $75.25, while ARHCF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas ARHCF's P/E ratio is 9.97. In terms of profitability, GALNF's ROE is +0.12%, compared to ARHCF's ROE of +0.06%. Regarding short-term risk, GALNF and ARHCF have similar daily volatility (0.00).Check ARHCF's competition here
GALNF vs SZUKF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, SZUKF has a market cap of 1.7B. Regarding current trading prices, GALNF is priced at $75.25, while SZUKF trades at $30.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas SZUKF's P/E ratio is 11.43. In terms of profitability, GALNF's ROE is +0.12%, compared to SZUKF's ROE of +0.08%. Regarding short-term risk, GALNF and SZUKF have similar daily volatility (0.00).Check SZUKF's competition here
GALNF vs MEDOF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, MEDOF has a market cap of 1.3B. Regarding current trading prices, GALNF is priced at $75.25, while MEDOF trades at $50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas MEDOF's P/E ratio is 73.53. In terms of profitability, GALNF's ROE is +0.12%, compared to MEDOF's ROE of +0.03%. Regarding short-term risk, GALNF is less volatile compared to MEDOF. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check MEDOF's competition here
GALNF vs ARRJF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, ARRJF has a market cap of 836.2M. Regarding current trading prices, GALNF is priced at $75.25, while ARRJF trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas ARRJF's P/E ratio is 18.06. In terms of profitability, GALNF's ROE is +0.12%, compared to ARRJF's ROE of +0.06%. Regarding short-term risk, GALNF is less volatile compared to ARRJF. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check ARRJF's competition here
GALNF vs IUSDF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, IUSDF has a market cap of 568.7M. Regarding current trading prices, GALNF is priced at $75.25, while IUSDF trades at $23.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas IUSDF's P/E ratio is 30.05. In terms of profitability, GALNF's ROE is +0.12%, compared to IUSDF's ROE of +0.09%. Regarding short-term risk, GALNF is less volatile compared to IUSDF. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check IUSDF's competition here
GALNF vs EXHI Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, EXHI has a market cap of 26.5M. Regarding current trading prices, GALNF is priced at $75.25, while EXHI trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas EXHI's P/E ratio is N/A. In terms of profitability, GALNF's ROE is +0.12%, compared to EXHI's ROE of +0.00%. Regarding short-term risk, GALNF is less volatile compared to EXHI. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check EXHI's competition here
GALNF vs NSVGF Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, NSVGF has a market cap of 8.5M. Regarding current trading prices, GALNF is priced at $75.25, while NSVGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas NSVGF's P/E ratio is -1.00. In terms of profitability, GALNF's ROE is +0.12%, compared to NSVGF's ROE of +0.21%. Regarding short-term risk, GALNF and NSVGF have similar daily volatility (0.00).Check NSVGF's competition here
GALNF vs PDRX Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, PDRX has a market cap of 3.7M. Regarding current trading prices, GALNF is priced at $75.25, while PDRX trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas PDRX's P/E ratio is 2.23. In terms of profitability, GALNF's ROE is +0.12%, compared to PDRX's ROE of -0.07%. Regarding short-term risk, GALNF is less volatile compared to PDRX. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check PDRX's competition here
GALNF vs KOSK Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, KOSK has a market cap of 2.9M. Regarding current trading prices, GALNF is priced at $75.25, while KOSK trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas KOSK's P/E ratio is -0.18. In terms of profitability, GALNF's ROE is +0.12%, compared to KOSK's ROE of -0.13%. Regarding short-term risk, GALNF and KOSK have similar daily volatility (0.00).Check KOSK's competition here
GALNF vs ENMI Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, ENMI has a market cap of 766.3K. Regarding current trading prices, GALNF is priced at $75.25, while ENMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas ENMI's P/E ratio is -0.02. In terms of profitability, GALNF's ROE is +0.12%, compared to ENMI's ROE of +0.51%. Regarding short-term risk, GALNF and ENMI have similar daily volatility (0.00).Check ENMI's competition here
GALNF vs ITNS Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, ITNS has a market cap of 609.4K. Regarding current trading prices, GALNF is priced at $75.25, while ITNS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas ITNS's P/E ratio is -0.04. In terms of profitability, GALNF's ROE is +0.12%, compared to ITNS's ROE of +0.01%. Regarding short-term risk, GALNF is less volatile compared to ITNS. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check ITNS's competition here
GALNF vs CHME Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, CHME has a market cap of 23.8K. Regarding current trading prices, GALNF is priced at $75.25, while CHME trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas CHME's P/E ratio is N/A. In terms of profitability, GALNF's ROE is +0.12%, compared to CHME's ROE of +0.04%. Regarding short-term risk, GALNF and CHME have similar daily volatility (0.00).Check CHME's competition here
GALNF vs PHRX Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, PHRX has a market cap of 5.2K. Regarding current trading prices, GALNF is priced at $75.25, while PHRX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas PHRX's P/E ratio is N/A. In terms of profitability, GALNF's ROE is +0.12%, compared to PHRX's ROE of +0.85%. Regarding short-term risk, GALNF is less volatile compared to PHRX. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check PHRX's competition here
GALNF vs MLTO Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, MLTO has a market cap of 1.7K. Regarding current trading prices, GALNF is priced at $75.25, while MLTO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas MLTO's P/E ratio is -0.00. In terms of profitability, GALNF's ROE is +0.12%, compared to MLTO's ROE of N/A. Regarding short-term risk, GALNF is less volatile compared to MLTO. This indicates potentially lower risk in terms of short-term price fluctuations for GALNF.Check MLTO's competition here
GALNF vs TGVN Comparison July 2025
GALNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GALNF stands at 3.7B. In comparison, TGVN has a market cap of 120. Regarding current trading prices, GALNF is priced at $75.25, while TGVN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GALNF currently has a P/E ratio of 20.23, whereas TGVN's P/E ratio is -0.00. In terms of profitability, GALNF's ROE is +0.12%, compared to TGVN's ROE of N/A. Regarding short-term risk, GALNF and TGVN have similar daily volatility (0.00).Check TGVN's competition here